Study for treatment of castration resistant metastatic prostate cancer

Primary disease category: Cancer

Secondary disease categories: Prostate Cancer

Sponsor: SWOG

Protocol number: A031201

Projected enrollment dates: June 2014 to December 2019

Official study title: Phase III Trial of Enzalutamide Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer